Prognostic significance of CDC25C in lung adenocarcinoma: an analysis of TCGA data

Lung adenocarcinoma (LUAD) is the most common and aggressive type of non-small cell lung cancer (NSCLC), accounting for around 40% of all lung cancers, and is an important cause of respiratory cancer deaths [1]. Lung and bronchus cancers represent 14% and 12% of all cancers in men and women, respectively, making it the second most frequent cancer in both sexes [2, 3]. The 5-year relative survival rate for lung cancer was 18% in 2007 –2013 [2]. LUAD is typically diagnosed at an advanced stage, after metastasis [4].
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Tags: Original Article Source Type: research